Immune response modulation by Galectin-1 in a transgenic model of neuroblastoma

Galectin-1 Accelerates Wound Healing by Regulating the Neuropilin-1/Smad3/NOX4 Pathway and ROS Production in Myofibroblasts

(2015) Yueh-Te Lin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

(2015) Thomas F Eleveld et al.   NATURE GENETICS

Mutational dynamics between primary and relapse neuroblastomas

(2015) Alexander Schramm et al.   NATURE GENETICS

Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application

(2015) Jiali Sun et al.   Journal for ImmunoTherapy of Cancer

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma

(2015) Alex Cazes et al.   Oncotarget

Sox2 Requirement in Sonic Hedgehog-Associated Medulloblastoma

(2013) J. Ahlfeld et al.   CANCER RESEARCH

Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma

(2013) Lena-Maria Carlson et al.   CARCINOGENESIS

Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells

(2013) Kristian W. Pajtler et al.   INTERNATIONAL JOURNAL OF CANCER

Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity

(2013) Tina Verschuere et al.   INTERNATIONAL JOURNAL OF CANCER

Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC

(2012) Fredrik J. Swartling et al.   CANCER CELL

Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease

(2012) T. Dalotto-Moreno et al.   CANCER RESEARCH

Neuropilin 1 deficiency on CD4+Foxp3+regulatory T cells impairs mouse melanoma growth

(2012) Wiebke Hansen et al.   JOURNAL OF EXPERIMENTAL MEDICINE

MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells

(2012) J H Schulte et al.   ONCOGENE

Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments

(2011) Rocio Soldati et al.   INTERNATIONAL JOURNAL OF CANCER

Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity

(2010) V. L. Thijssen et al.   CANCER RESEARCH

Characterization of signaling function and expression of HLA class I molecules in medulloblastoma

(2010) Courtney Smith et al.   JOURNAL OF NEURO-ONCOLOGY

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness

(2009) F Cimmino et al.   ONCOGENE

A Simple PCR Method for Rapid Genotype Analysis of the TH-MYCN Transgenic Mouse

(2009) Seiki Haraguchi et al.   PLoS One